Evommune, Inc. Stock: price and insider trades · United States

This page follows insider dealings at Evommune, Inc. as filed with SEC (Form 4). 15 insiders have disclosed 37 filings since 18 October 2025.

Open-market activity splits into 3 purchases totalling €143k and 5 sales totalling €637k; 3 insiders sit on the buying side and 5 insiders on the selling side. The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives and 1 finance chief. Carver Kyle filed the largest sale, €357k, on 1 June 2026.

The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (10 July 2026) now reads 99 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

For context, the typical company on the same exchange (median of 5,810 companies) published 19 filings over the same period, against 37 filings here. The full history, which starts in 2025, counts 3 purchases against 5 sales.

For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.